Wire · opportunities
Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.
26 August 2026 · By Derek Watson · Wire by Fusion42
Published
26 August 2026
Topic
opportunities
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 26 August 2026 · Fusion42 review
Revolution Medicines received FDA approval for their daraxonrasib pill to treat pancreatic adenocarcinoma earlier than expected.
This Wire brief sits within Fusion42's coverage of Biotech, and 48 sources have reported it between 26 Aug 2026 and 16 Oct 2026.
◆ ◆ The Wire takeaway
Pancreatic cancer treatment options just expanded with a new FDA-approved pill. If you build oncology drugs or support biotech launches, this approval opens a faster path to market for similar therapies.
◆ Coverage
48 sources · first reported 26 Aug 2026 · latest 16 Oct 2026
- How the FDA Approval of Daraxonrasib Might Fuel Future Pancreatic Cancer Researchonclive.com · 16 October 2026
- Revolution's Rasonque Gets Broad Pancreatic Cancer Recommendation in Europegenomeweb.com · 15 October 2026
- Q&A: Daraxonrasib's Impact on Pancreatic Cancer Research & Patient Carephysiciansweekly.com · 5 October 2026
- Experimental pancreatic cancer drug offers new hope in major trialabc7.com · 4 October 2026
- Daraxonrasib for Pancreatic Cancermassgeneralbrigham.org · 2 October 2026
- Daraxonrasib Approval Signals a New Era for RAS-Targeted Therapy in Pancreatic Canceronclive.com · 29 September 2026
- Revolution Medicines Just Hit a Major Milestone. Is the Stock a Buy?theglobeandmail.com · 17 September 2026
- FDA Grants Breakthrough Therapy Designation to First-Line Daraxonrasib Plus Chemo in mPDAConclive.com · 15 September 2026
- Revolution Medicines' first pancreatic cancer therapy approval challenges Amgen's biotech ...app.dealroom.co · 11 September 2026
- FDA Approval of Daraxonrasib in Pancreatic Canceronclive.com · 11 September 2026
- FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancerascopost.com · 10 September 2026
- A Breakthrough Pancreatic Drug is also Showing Results in Treating Lung Cancermix93.com · 8 September 2026
- Did First RASONQUE (daraxonrasib) Approval and NEJM Data Just Shift Revolution ...simplywall.st · 7 September 2026
- Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancermedpagetoday.com · 3 September 2026
- Pancreatic cancer drug may hold promise for lung cancer as well, early study suggestsabcnews.com · 3 September 2026
- New pancreatic cancer drug gives South Portland man hope for longer lifepressherald.com · 3 September 2026
- Karmanos now offers FDA-approved Daraxonrasib (Rasonque) for metastatic pancreatic cancertoday.wayne.edu · 1 September 2026
- Karmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancermclaren.org · 31 August 2026
- Karmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancersg.finance.yahoo.com · 31 August 2026
- 'Miracle drug' used by Sasse receives FDA approvalpressreader.com · 30 August 2026
- Patients with the deadliest cancer finally have something that workssg.finance.yahoo.com · 29 August 2026
- 'I'm still here:' South Florida patients see early promising results from new pancreatic cancer pillsun-sentinel.com · 29 August 2026
- FDA approves first RAS-targeting drug for pancreatic cancerdrugdiscoverynews.com · 28 August 2026
- Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion ...currently.att.yahoo.com · 28 August 2026
- FDA approves pancreatic cancer pill as Tyler patient sees results in similar clinical trialkltv.com · 28 August 2026
- Stage 4 Maine cancer patient says new FDA-approved pill is buying him timewgme.com · 28 August 2026
- Revolution Medicines (RVMD) Wins FDA Approval For Metastatic Pancreatic Cancer Drugsimplywall.st · 28 August 2026
- FDA approves breakthrough pancreatic cancer drug Rasonquefoxnews.com · 28 August 2026
- FDA approves Revolution Medicines' first in class targeted therapy for metastatic pancreatic cancerpmlive.com · 27 August 2026
- Rep. Sewell Celebrates the FDA Approval of a New Drug for Pancreatic Cancersewell.house.gov · 27 August 2026
- FDA approves landmark pancreatic cancer drug that's shown to improve survivalabcnews.com · 27 August 2026
- FDA Approves Revolution-ary New Drug for Pancreatic Cancercancerhealth.com · 27 August 2026
- FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Canceroncodaily.com · 27 August 2026
- FDA approves Rasonque for pancreatic cancer: When it's available and costyahoo.com · 27 August 2026
- How Significant is the Approval of Daraxonrasib in Pancreatic Cancer?cancernetwork.com · 27 August 2026
- Pancreatic Cancer Drug Receives FDA Approvalkffhealthnews.org · 27 August 2026
- FDA approves pancreatic cancer drug that extends patients' liveswashingtonpost.com · 27 August 2026
- FDA Approves New Pancreatic Cancer Drug After Stunning Trial Resultsyahoo.com · 27 August 2026
- FDA approves breakthrough drug daraxonrasib to treat pancreatic cancerbbc.com · 27 August 2026
- Revolution's lifesaving pancreatic cancer drug wins speedy FDA approvalwtvbam.com · 27 August 2026
- FDA approves life-extending pancreatic cancer drug Rasonqueusatoday.com · 27 August 2026
- Revolution Medicines gets FDA nod for targeted pancreatic cancer drugdetroitnews.com · 26 August 2026
- FDA Approves RAS Inhibitor Daraxonrasib for Pancreatic Cancermedscape.com · 26 August 2026
- FDA approves new pancreatic cancer drug shown to extend survivalspectrumlocalnews.com · 26 August 2026
- FDA Approval of Daraxonrasib: A New Era for Pancreatic Cancer Treatmentjhoponline.com · 26 August 2026
- FDA approves 'game-changing' pancreatic cancer drugnbcnews.com · 26 August 2026
- Dr Reiss Binder on the FDA Approval of Daraxonrasib for Metastatic PDAConclive.com · 26 August 2026
- Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drugajmc.com · 26 August 2026
- FDA approves breakthrough drug to treat advanced pancreatic cancerabcnews.com · 26 August 2026
- FDA OKs new pancreatic cancer drug trialed at Dana-Farberwcvb.com · 26 August 2026
- Daraxonrasib Gains FDA Approval for Pancreatic Canceroncologynewscentral.com · 26 August 2026
- Revolution Medicines gets FDA nod for targeted pancreatic cancer drugcnbc.com · 26 August 2026
- 'Grand Slam' Pancreatic Cancer Drug Wins FDA Approvalmedpagetoday.com · 26 August 2026
- Revolution Medicines gets FDA nod for targeted pancreatic cancer drugreuters.com · 26 August 2026
- FDA Approves First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancerhcplive.com · 26 August 2026
- FDA approves pancreatic cancer drug that nearly doubles survivalbeckersoncology.com · 26 August 2026
- FDA Approves Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinomaonclive.com · 26 August 2026
- FDA Approves Daraxonrasib for Previously Treated Metastatic Pancreatic Cancercancernetwork.com · 26 August 2026
- FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancerfda.gov · 26 August 2026
◆ Related on Wire
◆ Topics
BiotechFDA-approvalpancreatic-cancerpharmadrug-launch